Drugs / Influenza Virus Vaccine USP Trivalent Types A and B
Influenza Virus Vaccine USP Trivalent Types A and B
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01712984 Comparator | Oct 2012 → Jun 2013 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Virus Vaccine USP Trivalent Types A and B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01712984 ↗ |
| Modality | Vaccine | “trivalent influenza vaccine” NCT01712984 ↗ |